Advancements in Virus-Like Particles Production Services Using the VLPlant™ Platform
In biotechnology and pharmaceutical development, the demand for effective vaccine platforms has surged dramatically in recent years, particularly in response to global health crises such as the COVID-19 pandemic. Among the various solutions being explored, virus-like particles (VLPs) have
